Found 0 matching trials
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma PHASE2 Phase II study is being conducted to confirm the safety and efficacy of hig...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1 This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation NA Non-myeloablative allogeneic haematopoietic stem cell transplantation (NMA-...
Show More Location
Dep. of Hem. Aarhus Universitetshospital
Learn More & Join Trial
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus PHASE1 The Stanford Medical Center Division of Immunology and Rheumatology and the...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) PHASE1 The purpose of this study is to evaluate the safety, tolerability, and effi...
Show More Status
Active Not Recruiting
Location
University of California San Francisco
Learn More & Join Trial
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients NA This is a non-randomized, open-label, single-dose study. The aim of this st...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial PHASE3 ASSIST I was the first randomized trial in patients with scleroderma to not...
Show More Location
Northwestern University
Learn More & Join Trial
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) PHASE2 The purpose of this study is to determine the optimal regimen for the use o...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) PHASE2 This trial is looking at using umbilical cord blood from unrelated donors a...
Show More Location
University College London Hospital
Learn More & Join Trial